Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Safety of Mogamulizumab in Mycosis Fungoides and Sezary Syndrome: Final Results from the Phase 3 MAVORIC Study Sokol, L., Duvic, M., Musiek, A., Kim, E., Eradat, H., Elmets, C., Shinohara, M., Fisher, D., Poligone, B., Pro, B., Reddy, N., Halwani, A., Herr, F., Ito, T., Kim, Y. CIG MEDIA GROUP, LP. 2020: S253
View details for Web of Science ID 000564055100225